13F filer · CIK 1422848 ↗

Capital Research Global Investors

You are looking at Q3 2024. See the latest, Q2 2026 →

Reported value

$481.14B

+5.6% on the quarter before

Positions

415

35 new · 34 sold out

Top 10

31.7%

of the value

Est. gain

+$30.99B

on stocks held all quarter

Est. return

+7.3%

on those stocks since Q2 2024

Filed

Nov 13, 2024

On SEC EDGAR ↗

Positions as of Sep 30, 2024, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 50% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2024. Striped tiles are options.

Microsoft6.8%Meta4.4%Amazon3.6%Apple3.5%Broadcom3.3%
Unitedhealth Group Inc2.2%
Alphabet2.1%
Ge Aerospace2.1%
Rtx Corporation2.0%
Eli Lilly1.7%Carrier Global1.6%Nvidia1.6%Texas Instruments1.5%
Philip Morris Intl Inc1.4%
Salesforce1.4%
Abbvie Inc1.4%
Alphabet1.4%
Abbott Labs1.3%
Mastercard1.3%GE HealthCare1.1%
Royal Caribbean Group1.1%
Gilead Sciences Inc1.1%
Thermo Fisher Scientific Inc1.1%
Uber1.0%

Largest buys

Since Q2 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Las Vegas Sands Corp~$1.63BAdded · 0.1% → 0.5%+32,436,154 shares
  2. Pnc Finl Svcs Group Inc~$1.31BAdded · 0.2% → 0.5%+7,064,398 shares
  3. Uber~$975.3MAdded · 0.8% → 1.0%+12,975,737 shares
  4. Smurfit Westrock Plc~$895.5MNew · 0.0% → 0.2%+18,121,046 shares
  5. First Ctzns Bancshares Inc N~$798.4MAdded · 0.1% → 0.3%+433,700 shares
  6. International Paper Co~$767.8MAdded · 0.0% → 0.2%+15,718,166 shares
  7. Texas Instruments~$731.8MAdded · 1.4% → 1.5%+3,542,599 shares
  8. PayPal~$671.9MNew · 0.0% → 0.1%+8,610,323 shares
  9. Morgan Stanley~$666.6MAdded · 0.2% → 0.3%+6,394,808 shares
  10. Sea~$641.2MNew · 0.0% → 0.1%+6,800,881 shares

Largest sells

Since Q2 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Ge Aerospace~$2.09BCut · 2.2% → 2.1%−11,075,859 shares
  2. Cvs Health Corp~$1.87BCut · 0.5% → 0.1%−29,811,224 shares
  3. Nvidia~$1.49BCut · 2.0% → 1.6%−12,260,394 shares
  4. Rtx Corporation~$1.45BCut · 2.0% → 2.0%−11,995,762 shares
  5. Broadcom~$1.16BCut · 3.9% → 3.3%−6,719,093 shares
  6. Meta~$910.5MCut · 4.3% → 4.4%−1,590,526 shares
  7. Intel~$869.3MCut · 0.5% → 0.1%−37,056,024 shares
  8. Cenovus Energy Inc~$735.6MCut · 0.4% → 0.2%−43,983,618 shares
  9. Msci Inc~$683.3MSold out · 0.1% → 0.0%−1,418,385 shares
  10. Micron~$632.5MCut · 0.4% → 0.1%−6,098,337 shares

Holdings

As of Sep 30, 2024. Changes are in shares against Jun 30, 2024, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
MicrosoftCOM · shares −1.3% · price −3.7%6.8%$32.89B−$1.27B
MetaCL A · shares −4.1% · price +13.5%4.4%$21.40B+$2.55B
AmazonCOM · shares −0.1% · price −3.6%3.6%$17.26B−$641.0M
AppleCOM · shares +3.4% · price +10.6%3.5%$16.64B+$1.55B
BroadcomCOM · shares −6.8% · price −3.3%3.3%$15.95B−$544.8M
Unitedhealth Group IncCOM · shares +2.4% · price +14.8%2.2%$10.51B+$1.33B
AlphabetCAP STK CL A · shares +1.1% · price −8.9%2.1%$10.28B−$999.5M
Ge AerospaceCOM NEW · shares −17% · price +18.6%2.1%$9.92B+$1.56B
Rtx CorporationCOM · shares −13% · price +20.7%2.0%$9.63B+$1.65B
Eli LillyCOM · shares +1.6% · price −2.1%1.7%$8.21B−$177.3M
Carrier GlobalCOM · shares −0.3% · price +27.6%1.6%$7.66B+$1.66B
NvidiaCOM · shares −17% · price −1.7%1.6%$7.47B−$129.2M
Texas InstrumentsCOM · shares +11% · price +6.2%1.5%$7.46B+$392.0M
Philip Morris Intl IncCOM · shares −5.9% · price +19.8%1.4%$6.84B+$1.13B
SalesforceCOM · shares +0.8% · price +6.5%1.4%$6.66B+$401.4M
Abbvie IncCOM · shares +0.06% · price +15.1%1.4%$6.56B+$861.5M
AlphabetCAP STK CL C · shares −4.2% · price −8.9%1.4%$6.50B−$630.9M
Abbott LabsCOM · shares −6.9% · price +9.7%1.3%$6.08B+$538.3M
MastercardCL A · shares −4.4% · price +11.9%1.3%$6.02B+$641.2M
GE HealthCareCOMMON STOCK · shares +7.5% · price +20.4%1.1%$5.46B+$862.5M
Royal Caribbean GroupCOM · shares +0.8% · price +11.2%1.1%$5.41B+$542.8M
Gilead Sciences IncCOM · shares +2.3% · price +22.2%1.1%$5.18B+$920.3M
Thermo Fisher Scientific IncCOM · shares −0.6% · price +11.9%1.1%$5.06B+$536.8M
UberCOM · shares +24% · price +3.4%1.0%$4.96B+$131.6M
United Rentals IncCOM · shares +4.5% · price +25.2%1.0%$4.96B+$954.6M
Total · 415 positions100%$481.14B+$30.99B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2024 to Q3 2024: 380 stocks held throughout, up $30.99B (+7.3%).

  1. Meta+$2.55B+14%
  2. Carrier Global+$1.66B+28%
  3. Rtx Corporation+$1.65B+21%
  4. Ge Aerospace+$1.56B+19%
  5. Apple+$1.55B+11%
  6. Alphabet−$630.9M−9%
  7. Amazon−$641.0M−4%
  8. Boeing Co−$773.5M−16%
  9. Alphabet−$999.5M−9%
  10. Microsoft−$1.27B−4%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 3 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$800.00B$400.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$716.87B+11%SEC ↗
Q1 2026$644.56B+19%SEC ↗
Q4 2025$541.73B+2%SEC ↗
Q3 2025$532.97B+7%SEC ↗
Q2 2025$499.46B+9%SEC ↗
Q1 2025$459.90B−5%SEC ↗
Q4 2024$486.38B+1%SEC ↗
Q3 2024$481.14B+6%SEC ↗
Q2 2024$455.74B+3%SEC ↗
Q1 2024$441.98B+9%SEC ↗
Q4 2023$406.47B+12%SEC ↗
Q3 2023$363.16B−3%SEC ↗
Q2 2023$373.18B+7%SEC ↗
Q1 2023$350.40B+6%SEC ↗
Q4 2022$330.88B+9%SEC ↗
Q3 2022$304.37B−5%SEC ↗
Q2 2022$321.05B−21%SEC ↗
Q1 2022$405.10B−11%SEC ↗
Q4 2021$452.67B+6%SEC ↗
Q3 2021$428.65B−0%SEC ↗
Q2 2021$429.52B+5%SEC ↗
Q1 2021$408.71B+6%SEC ↗
Q4 2020$385.30B+16%SEC ↗
Q3 2020$333.11B+5%SEC ↗
Q2 2020$316.13B+24%SEC ↗
Q1 2020$254.90B−24%SEC ↗
Q4 2019$333.48B+9%SEC ↗
Q3 2019$304.85B−3%SEC ↗
Q2 2019$314.99B−0%SEC ↗
Q1 2019$315.45B+10%SEC ↗
Q4 2018$287.02B−17%SEC ↗
Q3 2018$344.02B−6%SEC ↗
Q2 2018$366.12B+4%SEC ↗
Q1 2018$351.43B+3%SEC ↗
Q4 2017$340.76B+3%SEC ↗
Q3 2017$331.24B+4%SEC ↗
Q2 2017$319.49B+1%SEC ↗
Q1 2017$317.04B+3%SEC ↗
Q4 2016$308.47B+2%SEC ↗
Q3 2016$302.53B+3%SEC ↗
Q2 2016$292.47B+1%SEC ↗
Q1 2016$290.06BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.